Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.

<h4>Background</h4>Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines fo...

Full description

Saved in:
Bibliographic Details
Main Authors: Shufei Fu, Junhua Zhang, Francesca Menniti-Ippolito, Xiumei Gao, Francesca Galeotti, Marco Massari, Limin Hu, Boli Zhang, Rita Ferrelli, Alice Fauci, Fabio Firenzuoli, Hongcai Shang, Ranieri Guerra, Roberto Raschetti
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-05-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0019604&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850110221872005120
author Shufei Fu
Junhua Zhang
Francesca Menniti-Ippolito
Xiumei Gao
Francesca Galeotti
Marco Massari
Limin Hu
Boli Zhang
Rita Ferrelli
Alice Fauci
Fabio Firenzuoli
Hongcai Shang
Ranieri Guerra
Roberto Raschetti
author_facet Shufei Fu
Junhua Zhang
Francesca Menniti-Ippolito
Xiumei Gao
Francesca Galeotti
Marco Massari
Limin Hu
Boli Zhang
Rita Ferrelli
Alice Fauci
Fabio Firenzuoli
Hongcai Shang
Ranieri Guerra
Roberto Raschetti
author_sort Shufei Fu
collection DOAJ
description <h4>Background</h4>Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL).<h4>Objectives</h4>To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge.<h4>Methods</h4>An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis.<h4>Results</h4>After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis.<h4>Conclusions</h4>Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market.
format Article
id doaj-art-ddcdf6767d204bfd86e68fd15e3d5a30
institution OA Journals
issn 1932-6203
language English
publishDate 2011-05-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-ddcdf6767d204bfd86e68fd15e3d5a302025-08-20T02:37:52ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-05-0165e1960410.1371/journal.pone.0019604Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.Shufei FuJunhua ZhangFrancesca Menniti-IppolitoXiumei GaoFrancesca GaleottiMarco MassariLimin HuBoli ZhangRita FerrelliAlice FauciFabio FirenzuoliHongcai ShangRanieri GuerraRoberto Raschetti<h4>Background</h4>Chronic heart failure (CHF) is a global public health problem. Therefore, novel and effective drugs that show few side-effects are needed. Early literature studies indicated that Huangqi injection is one of the most commonly used traditional Chinese patent medicines for CHF in China. As a large number of clinical studies has been carried out and published, it is essential to evaluate the effectiveness and safety of Huangqi injection. Therefore, we carried out this systematic review under the support of the framework of the Joint Sino-Italian Laboratory (JoSIL).<h4>Objectives</h4>To evaluate the efficacy and safety of Huangqi injection for CHF according to the available scientific knowledge.<h4>Methods</h4>An extensive search including PubMed, EMBASE, CBM, the Cochrane Library and Chinese literature databases was performed up to July 2008. Clinical trials regarding Huangqi injection for the treatment of CHF were searched for, irrespective of languages. The quality of each trial was assessed according to the Cochrane Reviewers' Handbook 5.0, and RevMan 5.0 provided by the Cochrane Collaboration and STATA 9.2 were used for data analysis.<h4>Results</h4>After selection of 1,205 articles, 62 RCTs and quasi-RCTs conducted in China and published in Chinese journals were included in the review. The methodological quality of the trials was low. In most trials inclusion and exclusion criteria were not specified. Furthermore, only one study evaluated the outcomes for drug efficacy after an adequate period of time. For these reasons and because of the different baseline characteristics we did not conduct a meta-analysis.<h4>Conclusions</h4>Although available studies are not adequate to draw a conclusion on the efficacy and safety of Huangqi injection (a traditional Chinese patent medicine), we hope that our work could provide useful experience on further studies on Huangqi injections. The overall level of TCM clinical research needs to be improved so that the efficacy of TCM can be evaluated by the international community and possibly some TCM can enter into the international market.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0019604&type=printable
spellingShingle Shufei Fu
Junhua Zhang
Francesca Menniti-Ippolito
Xiumei Gao
Francesca Galeotti
Marco Massari
Limin Hu
Boli Zhang
Rita Ferrelli
Alice Fauci
Fabio Firenzuoli
Hongcai Shang
Ranieri Guerra
Roberto Raschetti
Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
PLoS ONE
title Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
title_full Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
title_fullStr Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
title_full_unstemmed Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
title_short Huangqi injection (a traditional Chinese patent medicine) for chronic heart failure: a systematic review.
title_sort huangqi injection a traditional chinese patent medicine for chronic heart failure a systematic review
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0019604&type=printable
work_keys_str_mv AT shufeifu huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT junhuazhang huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT francescamennitiippolito huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT xiumeigao huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT francescagaleotti huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT marcomassari huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT liminhu huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT bolizhang huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT ritaferrelli huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT alicefauci huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT fabiofirenzuoli huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT hongcaishang huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT ranieriguerra huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview
AT robertoraschetti huangqiinjectionatraditionalchinesepatentmedicineforchronicheartfailureasystematicreview